Autism spectrum disorder (ASD) has been studied for many years, but there are still more questions than answers. For example, some research into the brain functions of individuals on the autism spectrum have found a lack of synchronization between different parts of the brain that normally work in tandem. But other studies have found the exact opposite — over-synchronization in the brains of those with ASD. A new study by Avital Hahamy and Prof. Rafi Malach of the Weizmann Institute's Neurobiology Department, and Prof. Marlene Behrmann of Carnegie Mellon University, Pittsburgh, which was recently published in Nature Neuroscience, suggests that the various reports may, in fact, reflect a deeper principle.

Three American Society for Radiation Oncology (ASTRO) staff members have been promoted to new positions: Emily Wilson has been named executive vice president; Dave Adler promoted to vice president of advocacy; and Anne Hubbard promoted to director of health policy, as announced by ASTRO’s board of directors and effective immediately.

A new study identifies several genes that together enable a lethal form of brain cancer to recur and progress after radiation therapy. The findings might lead to new therapies that target cancer stem cells, say researchers at The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James), who led the study.

Samsung Electronics America introduced the Samsung WS80A with Elite performance package, its flagship ultrasound product for women’s healthcare designed to streamline exam workflows and deliver image clarity.

BroadcastMed Inc. and Mercy Health present Jamie Caughran, M.D., FACS, fellowship trained breast surgeon at Mercy Health Comprehensive Breast Center in Grand Rapids, Mich. 

Ampronix announced the availability of the newest addition to the Modalixx line of medical modality monitors, the G202MDL.

Perhaps the biggest trend health information technology today is the movement away from traditional picture archiving and communications systems (PACS) and cardiovascular information systems (CVIS) to enterprise imaging and data management systems. This migration is important, because it will fundamentally change how clinicians have been accessing images and patient information for the past 20 years. 
 

IBA (Ion Beam Applications S.A.), a global high-tech leader in the next generation of proton therapy solutions and radiation therapy dosimetry for the treatment of cancer, is proud to support the Union for International Cancer Control (UICC) by participating in World Cancer Day on February 4, 2015.  IBA’s mission to “Protect, Enhance and Save Lives” reflects the understanding that lives are impacted by the efforts of all of IBA’s employees in developing the solutions, education and services for fighting cancer. World Cancer Day offers the perfect platform to take a moment and focus on this cause from a very personal aspect.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now